Screening assay for promigratory/antimigratory compounds

Analytical Biochemistry

Volumn 280, Issue 1, 2000, Pages 11-19

  Rust, Will L ^a   Huff, Janice L ^a   Plopper, George E ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

CAI; Cytotoxicity; Migration; Screening; Tamoxifen

Indexed keywords

CELL CULTURE; CELLS; COMPUTER AIDED INSTRUCTION; CYTOTOXICITY; DISEASES; SCREENING;

ANTICANCER COMPOUNDS; CANCER PROGRESSION; CYTOTOXIC COMPOUNDS; HAPTOTACTIC MIGRATION; MIGRATION; SCREENING ASSAYS; SCREENING STRATEGY; TAMOXIFEN;

DIAGNOSIS;

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER THERAPY; CELL MIGRATION; CHEMOTAXIS; CYTOTOXICITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0034630138     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2000.4510     Document Type: Article

References (35)

1. McKinnell R. G., Parchment R. E., Perantoni A. O., Pierce G. B. The Biological Basis of Cancer. 1998;Cambridge Univ. Press, Cambridge. p. 14-28.
2. Tannock I. F., Hill R. P. Tannock I. F., Hill R. P. The Basic Science of Oncology. 1992;302-337 McGraw-Hill, New York.
3. Kohn E. C., Liotta L. A. Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res. 55:1995;1856-1862.
4. Kee J. L., Hayes E. R. Pharmacology, a Nursing Process Approach. 1997;Saunders, Philadelphia. p. 408-422.
5. Hahnfeldt P., Panigrahy D., Folkman J., Hlatky L. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res. 59:1999;4770-4775.
6. Gruninger L., Cottin E., Li Y. X., Noel A., Ozsahin M., Coucke P. A. Sensitizing human cervical cancer cells in vitro to ionizing radiation with interferon beta or gamma. Radiat. Res. 152:1999;493-498.
7. Guerra-Vladusic F. K., Scott G., Weaver V., Vladusic E. A., Tsai M. S., Benz C. C., Lupu R. Constitutive expression of heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3. Int. J. Oncol. 15:1999;883-892.
8. Lode H. N., Moehler T., Xiang R., Jonczyk A., Gillies S. D., Cheresh D. A., Reisfeld R. A. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proc. Natl. Acad. Sci. USA. 96:1999;1591-1596.
9. Price J. T., Bonovich M. T., Kohn E. C. The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol. 32:1997;175-253.
10. Matsumoto K., Ziober B. L., Yao C., Kramer R. H. Growth factor regulation of integrin mediated cell motility. Cancer Metastasis Rev. 14:1995;205-217.
11. Lester B. R., McCarthy J. B. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev. 11:1992;31-44.
12. Bauer K. S., Figg W. D., Hamilton J. M., Jones E. C., Premkumar A., Steinberg S. M., Dyer V., Linehan W. M., Pluda J. M., Reed E. A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer. Clin. Cancer Res. 5:1999;2324-2329.
13. Lambert P. A., Somers K. D., Kohn E. C., Perry R. R. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery. 122:1997;372-379.
14. Wasilenko W. J., Palad A. J., Somers K. D., Blackmore P. F., Kohn E. C., Rhim J. S., Wright G. L. Jr., Schellhammer P. F. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int. J. Cancer. 68:1996;259-264.
15. Yangguan W., Palad A. J., Wasilenko W. J., Blackmore P. F., Pincus W. A., Schecter G. L., Spoonster J. R., Kohn E. C., Somers K. D. Inhibition of head and neck squamous cell carcinoma growth in invasion by the calcium influx inhibitor carboxyamido-triazole. Clin. Cancer Res. 3:1997;1915-1921.
16. Hupe D. J., Behrens N. D., Boltz R. Anti-proliferative activity of L-651,582 correlates with calcium-mediated regulation of nucleotide metabolism at phosphoribosyl pyrophosphate synthetase. J. Cell. Physiol. 144:1990;457-466.
17. Kohn E. C., Sandeen M. A., Liotta L. A. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res. 52:1992;3208-3212.
18. Kohn E. C., Jacobs W., Kim Y. S., Alessandro R., Stetler-Stevenson W. G., Liotta L. A. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J. Biol. Chem. 269:1994;21505-21511.
19. Plopper G. E., Domanico S. Z., Cirulli V., Kiosses W. B., Quaranta V. Migration of breast epithelial cells on Laminin-5: Differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51:1998;57-69.
20. Rust W., Kingsley K., Petnicki T., Padmanabhan S., Carper S. W., Plopper G. E. Heat shock protein 27 plays two distinct roles in controlling human breast cancer cell migration on laminin-5. Mol. Cell. Biol. Res. Commun. 1:1999;196-202.
21. Nieminen A. L., Gores G. J., Bond J. M., Imberti R., Herman B., Lemasters J. J. A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol. Appl. Pharmacol. 115:1992;147-155.
22. Goldberger, A, and, Septak, M. 1998, A Fluorescence Blocking Membrane Insert Enhances Analysis of Cell Motility Assays, Technical Bulletin 428, Becton Dickinson, Bedford, MA.
23. Haugland R. P. Handbook of Fluorescent Probes and Research Chemicals. 1996;Molecular Probes, Eugene.
24. Grever M. R., Schepartz S. A., Chabner B. A. The National Cancer Institute: Cancer drug discovery and development program. Semin. Oncol. 19:1992;622-638.
25. 51Cr-labeled polymorphonuclear leukocytes. J. Immunol. Methods. 120:1989;125-131.
26. Somersalo K., Salo O. P., Bjorksten F., Mustakallio K. K. A simplified Boyden chamber assay for neutrophil chemotaxis based on quantitation of myeloperoxidase. Anal. Biochem. 185:1990;238-242.
27. Grotendorst G. R. Spectrophotometric assay for the quantitation of cell migration in the Boyden chamber chemotaxis assay. Methods Enzymol. 147:1987;144-152.
28. Frevert C. W., Wong V. A., Goodman R. B., Goodwin R., Martin T. R. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods. 213:1998;41-52.
29. Howe A., Aplin A. E., Alahari S. K., Juliano R. L. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10:1998;220-231.
30. MacGregor J. I., Jordan V. C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50:1998;151-196.
31. Charlier C., Chariot A., Antoine N., Merville M. P., Gielen J., Castronovo V. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem. Pharmacol. 49:1995;351-358.
32. Shen F., Xue X., Weber G. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res. 19:1999;1657-1662.
33. Clark E. A., Brugge J. S. Integrins and signal transduction pathways: The road taken. Science. 268:1995;233-239.
34. Siegel G., Malmsten M., Klubendorf D. Tumor cell locomotion and metastatic spread. Microsc. Res. Tech. 43:1998;276-282.
35. Luzzi K. J., MacDonald I. C., Schmidt E. E., Kerkvlier N., Morris V. L., Chambers A. F., Groom A. C. Multistep nature of metastatic inefficiency. Am. J. Pathol. 153:1998;865-873.